Select Page

Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
Arslanian S, Hannon T, Philip Zeitler P, Chao L, Boucher-Berry C, Barrientos-Pérez M et al for the AWARD-PEDS Investigators
N Engl J Med 2022; 387:433-443
https://doi.org/10.1056/NEJMoa2204601

C peptide determination in the diagnosis of type one and its management: A clinical perspective
Maddaloni E, Bolli G, Randle R, Richard D, Pozzilli P, Buzzetti R et al
Diabetes Obesity and Metabolism
https://doi.org/10.1111/dom.14785

Sexual dysfunction in women with type 1 diabetes in Norway: A qualitative study of women’s experiences
Buskoven M, Kjørholt E, Strandberg R,  Søfteland E and  Haugstved A
Diabetic Medicine. 2022;39:e14856.
https://doi.org/10.1111/dme.14856

Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
Pop-Busui R,  Januzzi J, Bruemmer D, Butalia S,  J Green, Horton W et al
Diabetes Care June 2022, Vol.45, 1670-1690.
doi:https://doi.org/10.2337/dci22-0014

Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study 
Lee N,   Park S,  Kang D ,  Jeon J, H,  Kim D et al
Diabetes Care 2022;45(5):1141–1150
https://doi.org/10.2337/dc21-1659

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes
Koska J,  Gerstein H,  Beisswenger P,  Reaven P
DOI: 10.2337/dc21-2196 Diabetes Care 2022;1;45(3):684-691